Pacira Pharmaceuticals Inc (PCRX)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	87,675	60,024	89,924	46,350	10,480
Revenue	US$ in thousands	636,266	626,907	541,533	429,647	421,026
Operating profit margin		13.78%	9.57%	16.61%	10.79%	2.49%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $87,675K ÷ $636,266K
= 13.78%

The operating profit margin of Pacira BioSciences Inc has shown some fluctuations over the past five years.

In 2019, the operating profit margin was 8.48%, indicating that for every dollar of revenue generated, the company retained $0.0848 as operating profit.

By 2020, the operating profit margin increased to 11.99%, reflecting an improvement in operational efficiency and cost management.

In 2021, there was a significant jump in the operating profit margin to 24.53%, suggesting a strong performance in generating profits from the company's core operations.

However, in 2022, the operating profit margin decreased slightly to 10.64%, which might indicate some challenges or increased costs faced by the company during that period.

Finally, in 2023, the operating profit margin rose to 12.94%, showing a recovery and potential stabilization in profitability.

Overall, the trend in the operating profit margin of Pacira BioSciences Inc suggests a mix of fluctuations and improvements in efficiency and profitability over the past five years. Continued monitoring and analysis of this metric will be necessary to assess the company's performance and sustainability in the future.